Reynand Wu

The "PANSS" Paradox: Inside MapLight’s Volatile Market Reckoning and the Future of Schizophrenia Treatment

• Chemotherapy and Targeted Therapy

The "PANSS" Paradox: Inside MapLight’s Volatile Market Reckoning and the Future of Schizophrenia Treatment

Reynand Wu July 30, 2026

In the high-stakes world of psychiatric drug development, success is rarely a straight line, and even more...

Read More Read more about The "PANSS" Paradox: Inside MapLight’s Volatile Market Reckoning and the Future of Schizophrenia Treatment

Beyond the Checkbook: Redefining Corporate Social Responsibility Through Gifts-in-Kind

• Survivorship and Post-Treatment

Beyond the Checkbook: Redefining Corporate Social Responsibility Through Gifts-in-Kind

Reynand Wu July 29, 2026

By Madison Decker, Charitable Advancement Manager, National Breast Cancer Foundation (NBCF) With additional contributions from Katie Mooneyham,...

Read More Read more about Beyond the Checkbook: Redefining Corporate Social Responsibility Through Gifts-in-Kind

The Radical Act of Finding Grace: Redefining the "Spa" Experience Amidst Chemotherapy

• Survivorship and Post-Treatment

The Radical Act of Finding Grace: Redefining the "Spa" Experience Amidst Chemotherapy

Reynand Wu July 29, 2026

Introduction: A Sanctuary in the Clinical In the sterile, high-stakes environment of an oncology infusion center, the...

Read More Read more about The Radical Act of Finding Grace: Redefining the "Spa" Experience Amidst Chemotherapy

Embracing the Inevitable: Why Planning for the End is the Ultimate Act of Living

• Survivorship and Post-Treatment

Embracing the Inevitable: Why Planning for the End is the Ultimate Act of Living

Reynand Wu July 27, 2026

By Editorial Staff May 26, 2026 In the book of Deuteronomy, the ancient directive is clear: "Choose...

Read More Read more about Embracing the Inevitable: Why Planning for the End is the Ultimate Act of Living

Beyond Philanthropy: Forging Impactful Corporate-Nonprofit Partnerships for Mutual Growth

• Patient Advocacy and Support

Beyond Philanthropy: Forging Impactful Corporate-Nonprofit Partnerships for Mutual Growth

Reynand Wu July 26, 2026

By Katie Mooneyham and Candace Day, NBCF Staff In today’s dynamic business landscape, corporate social responsibility (CSR)...

Read More Read more about Beyond Philanthropy: Forging Impactful Corporate-Nonprofit Partnerships for Mutual Growth

Preparing for a Shift: The 2027 Medicaid Work Requirement Mandate

• Breast Cancer Legislation and Policy

Preparing for a Shift: The 2027 Medicaid Work Requirement Mandate

Reynand Wu July 25, 2026

The landscape of American public health coverage is bracing for a significant transformation. Under the provisions of...

Read More Read more about Preparing for a Shift: The 2027 Medicaid Work Requirement Mandate

Edwards Lifesciences Surges: TAVR Dominance Propels Financial Outlook Upgrade

• Treatment Innovations

Edwards Lifesciences Surges: TAVR Dominance Propels Financial Outlook Upgrade

Reynand Wu July 24, 2026

In a powerful demonstration of market resilience and clinical innovation, Edwards Lifesciences has solidified its position as...

Read More Read more about Edwards Lifesciences Surges: TAVR Dominance Propels Financial Outlook Upgrade

Advocating for Scientific Integrity: METAvivor Challenges Federal Funding Revisions in OMB-2026-0034

• Patient Advocacy and Support

Advocating for Scientific Integrity: METAvivor Challenges Federal Funding Revisions in OMB-2026-0034

Reynand Wu July 24, 2026

In a move to safeguard the future of biomedical innovation, METAvivor, a leading non-profit organization dedicated to...

Read More Read more about Advocating for Scientific Integrity: METAvivor Challenges Federal Funding Revisions in OMB-2026-0034

GSK Accelerates Oncology Ambitions with Landmark FDA Approval of Jideytro

• Chemotherapy and Targeted Therapy

GSK Accelerates Oncology Ambitions with Landmark FDA Approval of Jideytro

Reynand Wu July 23, 2026

In a decisive move that underscores its aggressive pivot toward the oncology sector, British pharmaceutical giant GSK...

Read More Read more about GSK Accelerates Oncology Ambitions with Landmark FDA Approval of Jideytro

Bridging the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries

• Metastatic Breast Cancer Research

Bridging the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries

Reynand Wu July 23, 2026

In a significant move aimed at reshaping the landscape of oncology research, the metastatic breast cancer advocacy...

Read More Read more about Bridging the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries